Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-26-001571
Filing Date
2026-03-20
Accepted
2026-03-20 16:05:20
Documents
5
Period of Report
2026-03-20

Document Format Files

Seq Description Document Type Size
1 6-K zk2634884.htm 6-K 10089
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 252283
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 31161
4 image0.jpg GRAPHIC 305530
5 image00002.jpg GRAPHIC 234153
  Complete submission text file 0001178913-26-001571.txt   1037938
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 26778249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)